Due to the government shutdown, updates to information on this website may be limited or delayed. State Medicaid and Children’s Health Insurance Programs (CHIP) continue to operate. Continue to work with the programs in your state to access coverage. For more information about government operating status, visit OPM.gov.

U.S. flag

An official website of the United States government

Federal Disaster Resources

This page provides federal resources that are helpful during emergencies and disasters. We also created Medicaid & CHIP disaster preparedness toolkits to provide states and territories with additional disaster-related information.

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of South Carolina for multiple section 1135 flexibilities on March 31, 2020. Your follow-up communication to CMS on January 14, 2021 indicated South Carolina’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Nevada for multiple section 1135 flexibilities on April 7, 2020. Your follow-up communication to CMS on January 12, 2021 indicated Nevada’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Missouri for multiple section 1135 flexibilities on March 25, 2020. Your follow-up communication to CMS on January 11, 2021 indicated Missouri’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Missouri for multiple section 1135 flexibilities on March 25, 2020. Your follow-up communication to CMS on February 16, 2021, detailed a number of additional federal requirements that also pose issues or challenges for the health care delivery system in Missouri and requested a waiver or modification of those additional requirements.

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Minnesota for multiple section 1135 flexibilities on March 27, 2020. Your follow-up communication to CMS on February 10, 2021, indicated Minnesota’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Maine for multiple section 1135 flexibilities on April 7, 2020. Your follow-up communication to CMS on February 12, 2021 indicated Maine’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Louisiana for multiple section 1135 flexibilities on March 23, 2020. Your follow-up communication to CMS on January 19, 2021 indicated Louisiana’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Idaho for multiple section 1135 flexibilities on March 26, 2020. Your follow-up communication to CMS on January 7, 2021, indicated Idaho’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Iowa for multiple section 1135 flexibilities on March 25, 2020. Your follow-up communication to CMS on January 12, 2021, indicated Iowa’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Florida for multiple section 1135 flexibilities on March 16, 2020. Your follow-up communication to CMS on February 9, 2021 indicated Florida’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
Show entries